Status: Recruiting
Efficacy, Safety, and Tolerability of Encaleret in Participants With Chronic Hypoparathyroidism
The aim of the study is to evaluate the efficacy, safety, and tolerability of orally administered encaleret tablets in participants with chronic hypoparathyroidism (HP).
Participants needed: 160
Trial details
Phase: Phase 3Age: 16+Biological sex: AllType: InterventionalSponsor: Calcilytix Therapeutics, Inc., a BridgeBio companyUpdated: Sep 16, 2026Locations: 5
Eligibility criteria
Participants must have had a clinically confirmed diagnosis of chronic HP, with... [+9]
Genetically confirmed diagnosis of autosomal dominant hypocalcemia type 1 (ADH1)... [+4]